Pharmaceuticals - Mozambique

Mozambique

In 2024, the projected revenue in the Pharmaceuticals market in Mozambique is estimated to reach US$158.80m.
Among the various markets, the largest one is Oncology Drugs, which is expected to have a market volume of US$27.32m in the same year.
Looking ahead, the revenue is anticipated to exhibit an annual growth rate (CAGR 2024-2028) of 7.02%, resulting in a market volume of US$208.30m by 2028.
It is worth noting that in a global context, United States is expected to generate the highest revenue with an estimated amount of US$636.90bn in 2024.
Mozambique's pharmaceutical market is experiencing a surge in demand for essential medicines due to the country's growing population and increasing healthcare needs.

Key regions: United States, China, Germany, Japan, Europe

Definition:
The Pharmaceuticals market covers remedies used to cure, treat, prevent, and diagnose diseases. These small molecule drugs or biologic medical products may be called drugs, medications, or medicines. Prescription drugs and over-the-counter (OTC) drugs are both included. Depending on the regulations in each country, these products are provided by pharmacies, hospitals, physicians, and/or drug stores, and/or they can be bought elsewhere. They may be administered in the form of pills, capsules, gels, ointments, injections, infusions, lozenges, or aerosols/sprays.

Structure:
The market is subdivided into Oncology Drugs, Anti-Diabetes Drugs, Anti-Rheumatic Drugs, Vaccines, Dermatological Drugs, Antiviral Drugs, Immunosuppressants, Bronchodilator Drugs, Sensory Organ Drugs, Anti-Hypertensive Drugs, Anti-Coagulants, Anti-Fibrinolytic Drugs, Multiple Sclerosis Drugs, Lipid-Lowering Agents and Other Pharmaceuticals. The Pharmaceuticals market is organized in markets that cover drugs used in specific medical fields, i.e., medicines for a specific disesase or a certain type of medicine. They include original brands, biosimilars, generics, and orphan drugs.The Oncology Drugs market covers pharmaceutical products specifically developed for the treatment and management of various cancers. The Anti-Diabetes Drugs market covers medications designed to manage blood glucose levels and improve insulin sensitivity in individuals with diabetes. The market Anti-Rheumatic Drugs includes pharmaceuticals specifically developed to alleviate symptoms, reduce inflammation, and modify the progression of rheumatic diseases. The Dermatological Drugs market covers pharmaceuticals formulated to treat and manage a wide range of skin conditions such as eczema, acne, and rosacea. The Antiviral Drugs market includes medications designed to treat viral infections and reducing the severity and duration of symptoms. The Immunosuppressants market covers pharmaceuticals that suppress the immune system's activity. The Bronchodilator Drugs market covers pharmaceuticals designed to relax and widen the airways in the lungs. The Sensory Organ Drugs market covers pharmaceuticals targeting the treatment of disorders and conditions affecting sensory organs such as the eyes, ears and nose. The Anti-hypertensive Drugs market covers pharmaceuticals designed to lower blood pressure levels. The Anti-Coagulants Drugs market covers pharmaceuticals developed to prevent the formation of blood clots or to dissolve existing clots. The Anti-Fibrinolytics Drugs market covers pharmaceuticals designed to inhibit the breakdown of blood clots. The Multiple Sclerosis Drugs market covers pharmaceuticals aimed at managing and modifying the course of multiple sclerosis. The Lipid-Lowering Agents market covers pharmaceuticals developed to reduce levels of cholesterol and other lipids in the blood. The Other Pharmaceuticals market provides information on additional specialties that are not covered by the main markets.

Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Novartis, Roche, Pfizer, Merck & Co, Johnson & Johnson, AbbVie, Sanofi.

Market

Region

Region comparison

Currency

Analyst Opinion

The Pharmaceuticals market in Mozambique has been steadily growing in recent years, driven by a number of factors.

Customer preferences: Mozambique has a large population with a high burden of disease, particularly infectious diseases such as HIV/AIDS, malaria, and tuberculosis. As a result, there is a high demand for pharmaceutical products to treat and manage these conditions. In addition, there is a growing middle class in Mozambique with increased purchasing power, which is driving demand for higher quality and more expensive pharmaceutical products.

Trends in the market: One of the main trends in the Mozambique Pharmaceuticals market is the increasing prevalence of non-communicable diseases (NCDs) such as diabetes, hypertension, and cancer. This is partly due to changing lifestyles and diets, as well as an aging population. As a result, there is a growing demand for pharmaceutical products to treat and manage NCDs. Another trend is the increasing use of generic drugs, which are often more affordable than branded drugs and can help to increase access to healthcare.

Local special circumstances: Mozambique is a low-income country with limited healthcare infrastructure, which presents a number of challenges for the pharmaceutical industry. For example, there is a lack of trained healthcare professionals and a shortage of medical equipment and supplies. In addition, the country is vulnerable to natural disasters such as cyclones and floods, which can disrupt supply chains and cause shortages of essential medicines.

Underlying macroeconomic factors: Mozambique has experienced strong economic growth in recent years, driven by natural resource exports and foreign investment. However, the country remains one of the poorest in the world, with high levels of poverty and inequality. This has implications for the pharmaceutical industry, as many Mozambicans may not be able to afford essential medicines. In addition, the country is heavily dependent on imports for pharmaceutical products, which makes it vulnerable to currency fluctuations and supply chain disruptions.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.